000 01192 a2200349 4500
005 20250512090854.0
264 0 _c19720822
008 197208s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM197208032870512
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoche, J K
245 0 0 _aClinical trials of hepatitis B immune globulin.
_h[electronic resource]
260 _bThe New England journal of medicine
_cAug 1972
300 _a251-2 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aChild
650 0 4 _aClinical Trials as Topic
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aFollow-Up Studies
650 0 4 _aHepatitis A
_ximmunology
650 0 4 _aHepatitis B
_xprevention & control
650 0 4 _aHospitals
650 0 4 _aHumans
650 0 4 _aImmunoglobulins
_xadverse effects
650 0 4 _aSchools, Medical
650 0 4 _aUnited States
650 0 4 _agamma-Globulins
_xtherapeutic use
700 1 _aStengle, J M
773 0 _tThe New England journal of medicine
_gvol. 287
_gno. 5
_gp. 251-2
856 4 0 _uhttps://doi.org/10.1056/NEJM197208032870512
_zAvailable from publisher's website
999 _c4119644
_d4119644